263 related articles for article (PubMed ID: 20732712)
1. The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy.
Kempe M; Kempe H; Snowball I; Wallén R; Arza CR; Götberg M; Olsson T
Biomaterials; 2010 Dec; 31(36):9499-510. PubMed ID: 20732712
[TBL] [Abstract][Full Text] [Related]
2. Targeting to carcinoma cells with chitosan- and starch-coated magnetic nanoparticles for magnetic hyperthermia.
Kim DH; Kim KN; Kim KM; Lee YK
J Biomed Mater Res A; 2009 Jan; 88(1):1-11. PubMed ID: 18257079
[TBL] [Abstract][Full Text] [Related]
3. Temperature-responsive magnetite/PEO-PPO-PEO block copolymer nanoparticles for controlled drug targeting delivery.
Chen S; Li Y; Guo C; Wang J; Ma J; Liang X; Yang LR; Liu HZ
Langmuir; 2007 Dec; 23(25):12669-76. PubMed ID: 17988160
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal magnetic drug targeting using gold-coated magnetite nanoparticles in a human spine model.
Lueshen E; Venugopal I; Kanikunnel J; Soni T; Alaraj A; Linninger A
Nanomedicine (Lond); 2014; 9(8):1155-69. PubMed ID: 23862614
[TBL] [Abstract][Full Text] [Related]
5. Covalent immobilization of porcine pancreatic lipase on carboxyl-activated magnetic nanoparticles: characterization and application for enzymatic inhibition assays.
Zhu YT; Ren XY; Liu YM; Wei Y; Qing LS; Liao X
Mater Sci Eng C Mater Biol Appl; 2014 May; 38():278-85. PubMed ID: 24656379
[TBL] [Abstract][Full Text] [Related]
6. Magnetorelaxometric quantification of magnetic nanoparticles in an artery model after ex vivo magnetic drug targeting.
Richter H; Wiekhorst F; Schwarz K; Lyer S; Tietze R; Alexiou Ch; Trahms L
Phys Med Biol; 2009 Sep; 54(18):N417-24. PubMed ID: 19700820
[TBL] [Abstract][Full Text] [Related]
7. The synthesis and characterization of poly(γ-glutamic acid)-coated magnetite nanoparticles and their effects on antibacterial activity and cytotoxicity.
Inbaraj BS; Kao TH; Tsai TY; Chiu CP; Kumar R; Chen BH
Nanotechnology; 2011 Feb; 22(7):075101. PubMed ID: 21233545
[TBL] [Abstract][Full Text] [Related]
8. The formulation, characterization and in vivo evaluation of a magnetic carrier for brain delivery of NIR dye.
Raut SL; Kirthivasan B; Bommana MM; Squillante E; Sadoqi M
Nanotechnology; 2010 Oct; 21(39):395102. PubMed ID: 20820096
[TBL] [Abstract][Full Text] [Related]
9. Microcapsules of alginate/chitosan containing magnetic nanoparticles for controlled release of insulin.
Finotelli PV; Da Silva D; Sola-Penna M; Rossi AM; Farina M; Andrade LR; Takeuchi AY; Rocha-Leão MH
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):206-11. PubMed ID: 20688491
[TBL] [Abstract][Full Text] [Related]
10. Isolated swine heart ventricle perfusion model for implant assisted-magnetic drug targeting.
Avilés MO; Mangual JO; Ebner AD; Ritter JA
Int J Pharm; 2008 Sep; 361(1-2):202-8. PubMed ID: 18573319
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes.
Murciano JC; Medinilla S; Eslin D; Atochina E; Cines DB; Muzykantov VR
Nat Biotechnol; 2003 Aug; 21(8):891-6. PubMed ID: 12845330
[TBL] [Abstract][Full Text] [Related]
12. Surfactant-assisted one-pot synthesis of superparamagnetic magnetite nanoparticle clusters with tunable cluster size and magnetic field sensitivity.
Togashi T; Naka T; Asahina S; Sato K; Takami S; Adschiri T
Dalton Trans; 2011 Feb; 40(5):1073-8. PubMed ID: 21173987
[TBL] [Abstract][Full Text] [Related]
13. Delivery of tissue plasminogen activator and streptokinase magnetic nanoparticles to target vascular diseases.
Tadayon A; Jamshidi R; Esmaeili A
Int J Pharm; 2015 Nov; 495(1):428-438. PubMed ID: 26363110
[TBL] [Abstract][Full Text] [Related]
14. Simple synthesis of functionalized superparamagnetic magnetite/silica core/shell nanoparticles and their application as magnetically separable high-performance biocatalysts.
Lee J; Lee Y; Youn JK; Na HB; Yu T; Kim H; Lee SM; Koo YM; Kwak JH; Park HG; Chang HN; Hwang M; Park JG; Kim J; Hyeon T
Small; 2008 Jan; 4(1):143-52. PubMed ID: 18189246
[TBL] [Abstract][Full Text] [Related]
15. Magnetic targeting after femoral artery administration and biocompatibility assessment of superparamagnetic iron oxide nanoparticles.
Ma HL; Qi XR; Ding WX; Maitani Y; Nagai T
J Biomed Mater Res A; 2008 Mar; 84(3):598-606. PubMed ID: 17618488
[TBL] [Abstract][Full Text] [Related]
16. Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: core-shell nanoparticle carrier and drug release response.
Zhang J; Misra RD
Acta Biomater; 2007 Nov; 3(6):838-50. PubMed ID: 17638599
[TBL] [Abstract][Full Text] [Related]
17. Analysis of trajectories for targeting of magnetic nanoparticles in blood vessels.
Heidsieck A; Vosen S; Zimmermann K; Wenzel D; Gleich B
Mol Pharm; 2012 Jul; 9(7):2029-38. PubMed ID: 22663555
[TBL] [Abstract][Full Text] [Related]
18. Cancer hyperthermia using magnetic nanoparticles.
Kobayashi T
Biotechnol J; 2011 Nov; 6(11):1342-7. PubMed ID: 22069094
[TBL] [Abstract][Full Text] [Related]
19. Computational Assessment of Unsteady Flow Effects on Magnetic Nanoparticle Targeting Efficiency in a Magnetic Stented Carotid Bifurcation Artery.
Hewlin RL; Smith M; Kizito JP
Cardiovasc Eng Technol; 2023 Oct; 14(5):694-712. PubMed ID: 37723333
[TBL] [Abstract][Full Text] [Related]
20. Cellular response to magnetic nanoparticles "PEGylated" via surface-initiated atom transfer radical polymerization.
Hu F; Neoh KG; Cen L; Kang ET
Biomacromolecules; 2006 Mar; 7(3):809-16. PubMed ID: 16529418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
